AngioDynamics files initial beneficial ownership statement for President, CEO and Director Eric Honroth
ANGO•AngioDynamics President, CEO and director Eric Honroth signed an initial statement of beneficial ownership on Nov. 4, 2026.
ANGO•AngioDynamics President, CEO and director Eric Honroth signed an initial statement of beneficial ownership on Nov. 4, 2026.
AngioDynamics President, CEO and director Eric Honroth signed an initial statement of beneficial ownership on Nov. 4, 2026.